Literature DB >> 11453556

Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells.

R R Adams1, D M Eckley, P Vagnarelli, S P Wheatley, D L Gerloff, A M Mackay, P A Svingen, S H Kaufmann, W C Earnshaw.   

Abstract

The inner centromere protein (INCENP), which has previously been described in chicken, frog and mouse, is required for correct chromosome segregation and cytokinesis. We have identified the human INCENP gene by library screening and reverse transcription-polymerase chain reaction (RT-PCR) and localized it to chromosomal region 11q12. HsINCENP is a single-copy gene that consists of 17 exons and covers 25 kb of genomic DNA. The gene is expressed at highest levels in the colon, testis and prostate, consistent with its likely role in cell proliferation. HsINCENP encodes a highly basic protein of 915 amino acids that localizes to metaphase chromosomes and to the mitotic spindle and equatorial cortex at anaphase. Recently we showed that INCENP is stockpiled in a complex with the Aurora-B/XAIRK2 kinase in Xenopus eggs. Here we demonstrate that, consistent with such an interaction, the two proteins colocalize on human metaphase chromosomes. Levels of Aurora-B are increased in several human cancers, and we show here that HsINCENP protein levels are also significantly increased in several colorectal cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453556     DOI: 10.1007/s004120100130

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  39 in total

1.  Pericentric heterochromatin becomes enriched with H2A.Z during early mammalian development.

Authors:  Danny Rangasamy; Leise Berven; Patricia Ridgway; David John Tremethick
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

Review 2.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Xenopus Shugoshin 2 regulates the spindle assembly pathway mediated by the chromosomal passenger complex.

Authors:  Teresa Rivera; Cristina Ghenoiu; Miriam Rodríguez-Corsino; Satoru Mochida; Hironori Funabiki; Ana Losada
Journal:  EMBO J       Date:  2012-01-24       Impact factor: 11.598

4.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors:  O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

5.  Aurora kinase B modulates chromosome alignment in mouse oocytes.

Authors:  Kristy Shuda; Karen Schindler; Jun Ma; Richard M Schultz; Peter J Donovan
Journal:  Mol Reprod Dev       Date:  2009-11       Impact factor: 2.609

Review 6.  Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.

Authors:  Patrick Salaun; Yoann Rannou; Claude Prigent
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Localization of aurora A and aurora B kinases during interphase: role of the N-terminal domain.

Authors:  Yoann Rannou; Marie-Bérengère Troadec; Clotilde Petretti; Fabienne Hans; Stéphanie Dutertre; Stefan Dimitrov; Claude Prigent
Journal:  Cell Cycle       Date:  2008-10-26       Impact factor: 4.534

8.  Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation.

Authors:  Margaret A Bolton; Weijie Lan; Shannon E Powers; Mark L McCleland; Jian Kuang; P Todd Stukenberg
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

9.  High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas.

Authors:  Kasumi Araki; Kazuhiko Nozaki; Tetsuya Ueba; Masaaki Tatsuka; Nobuo Hashimoto
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Molecular architecture and assembly of the yeast kinetochore MIND complex.

Authors:  Daniel P Maskell; Xiao-Wen Hu; Martin R Singleton
Journal:  J Cell Biol       Date:  2010-09-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.